The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Gian Paolo Rossi

Department of Health Science

University of Milan-Bicocca

Milan

Italy

[email]@unipd.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Health Science, University of Milan-Bicocca, Milan, Italy. 2013
  • Department of Medicine-DIMED, Internal Medicine 4, University Hospital, via Giustiniani 2, Italy. 2001 - 2012
  • Cardiac and Thoracic Department, University of Pisa, Italy. 2002

References

  1. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Rossi, G.P., Cesari, M., Cuspidi, C., Maiolino, G., Cicala, M.V., Bisogni, V., Mantero, F., Pessina, A.C. Hypertension (2013) [Pubmed]
  2. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma. Rossi, G.P., Ragazzo, F., Seccia, T.M., Maniero, C., Barisa, M., Calò, L.A., Frigo, A.C., Fassina, A., Pessina, A.C. Hypertension (2012) [Pubmed]
  3. The Adrenal Vein Sampling International Study (AVIS) for Identifying the Major Subtypes of Primary Aldosteronism. Rossi, G.P., Barisa, M., Allolio, B., Auchus, R.J., Amar, L., Cohen, D., Degenhart, C., Deinum, J., Fischer, E., Gordon, R., Kickuth, R., Kline, G., Lacroix, A., Magill, S., Miotto, D., Naruse, M., Nishikawa, T., Omura, M., Pimenta, E., Plouin, P.F., Quinkler, M., Reincke, M., Rossi, E., Rump, L.C., Satoh, F., Schultze Kool, L., Seccia, T.M., Stowasser, M., Tanabe, A., Trerotola, S., Vonend, O., Widimsky, J., Wu, K.D., Wu, V.C., Pessina, A.C. J. Clin. Endocrinol. Metab. (2012) [Pubmed]
  4. Chromogranin a measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism. Seccia, T.M., Miotto, D., De Toni, R., Maniero, C., Vincenzi, M., Motta, R., Pessina, A.C., Rossi, G.P. J. Clin. Endocrinol. Metab. (2011) [Pubmed]
  5. Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Rossi, G.P., Seccia, T.M., Palumbo, G., Belfiore, A., Bernini, G., Caridi, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mallamaci, F., Mannelli, M., Patalano, A., Rizzoni, D., Rossi, E., Pessina, A.C., Mantero, F. Hypertension (2010) [Pubmed]
  6. The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. Rossi, G.P., Barisa, M., Belfiore, A., Desideri, G., Ferri, C., Letizia, C., Maccario, M., Morganti, A., Palumbo, G., Patalano, A., Roman, E., Seccia, T.M., Pessina, A.C., Mantero, F. J. Hypertens. (2010) [Pubmed]
  7. Primary aldosteronism: part II: subtype differentiation and treatment. Rossi, G.P., Seccia, T.M., Pessina, A.C. J. Nephrol. (2008) [Pubmed]
  8. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. Rossi, G.P., Belfiore, A., Bernini, G., Fabris, B., Caridi, G., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., Palumbo, G., Patalano, A., Rizzoni, D., Rossi, E., Pessina, A.C., Mantero, F. J. Clin. Endocrinol. Metab. (2008) [Pubmed]
  9. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Rossi, G.P., Bolognesi, M., Rizzoni, D., Seccia, T.M., Piva, A., Porteri, E., Tiberio, G.A., Giulini, S.M., Agabiti-Rosei, E., Pessina, A.C. Hypertension (2008) [Pubmed]
  10. Primary aldosteronism: an update on screening, diagnosis and treatment. Rossi, G.P., Pessina, A.C., Heagerty, A.M. J. Hypertens. (2008) [Pubmed]
  11. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. Rossi, G.P., Pitter, G., Bernante, P., Motta, R., Feltrin, G., Miotto, D. J. Hypertens. (2008) [Pubmed]
  12. Primary aldosteronism - part I: prevalence, screening, and selection of cases for adrenal vein sampling. Rossi, G.P., Seccia, T.M., Pessina, A.C. J. Nephrol. (2008) [Pubmed]
  13. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. Rossi, G.P., Belfiore, A., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mallamaci, F., Mannelli, M., Montemurro, D., Palumbo, G., Rizzoni, D., Rossi, E., Semplicini, A., Agabiti-Rosei, E., Pessina, A.C., Mantero, F. J. Hypertens. (2007) [Pubmed]
  14. New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism. Rossi, G.P. Curr. Hypertens. Rep. (2007) [Pubmed]
  15. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Rossi, G.P., Belfiore, A., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mallamaci, F., Mannelli, M., Palumbo, G., Rizzoni, D., Rossi, E., Agabiti-Rosei, E., Pessina, A.C., Mantero, F. Hypertension (2007) [Pubmed]
  16. Homocysteine, left ventricular dysfunction and coronary artery disease: is there a link? Rossi, G.P., Seccia, T.M., Pessina, A.C. Clin. Chem. Lab. Med. (2007) [Pubmed]
  17. Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension. Rossi, G.P., Seccia, T.M., Pessina, A.C. Crit. Rev. Clin. Lab. Sci (2007) [Pubmed]
  18. Tissue kallikrein gene polymorphisms induce no change in endothelium-dependent or independent vasodilation in hypertensive and normotensive subjects. Rossi, G.P., Taddei, S., Ghiadoni, L., Virdis, A., Zavattiero, S., Favilla, S., Versari, D., Sudano, I., Azizi, M., Vedie, B., Pessina, A.C., Salvetti, A., Jeunemaitre, X. J. Hypertens. (2006) [Pubmed]
  19. Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. Rossi, G.P., Maiolino, G., Seccia, T.M., Burlina, A., Zavattiero, S., Cesari, M., Sticchi, D., Pedon, L., Zanchetta, M., Pessina, A.C. J. Hypertens. (2006) [Pubmed]
  20. Eating the health of your endothelium: is it too early to say?. Rossi, G.P. J. Hypertens. (2006) [Pubmed]
  21. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. Rossi, G.P., Ganzaroli, C., Miotto, D., De Toni, R., Palumbo, G., Feltrin, G.P., Mantero, F., Pessina, A.C. J. Hypertens. (2006) [Pubmed]
  22. Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas. Rossi, G.P., Sticchi, D., Giuliani, L., Bernante, P., Zavattiero, S., Pessina, A.C., Nussdorfer, G.G. Int. J. Mol. Med. (2006) [Pubmed]
  23. Renal damage in primary aldosteronism: results of the PAPY Study. Rossi, G.P., Bernini, G., Desideri, G., Fabris, B., Ferri, C., Giacchetti, G., Letizia, C., Maccario, M., Mannelli, M., Matterello, M.J., Montemurro, D., Palumbo, G., Rizzoni, D., Rossi, E., Pessina, A.C., Mantero, F. Hypertension (2006) [Pubmed]
  24. Genetic variation in the endothelin system: do polymorphisms affect the therapeutic strategies?. Rossi, G.P., Pitter, G. Ann. N. Y. Acad. Sci. (2006) [Pubmed]
  25. Surgically correctable hypertension caused by primary aldosteronism. Rossi, G.P. Best Pract. Res. Clin. Endocrinol. Metab. (2006) [Pubmed]
  26. Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists?. Rossi, G.P. Curr. Hypertens. Rep. (2006) [Pubmed]
  27. Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?. Rossi, G.P. Curr. Hypertens. Rep. (2004) [Pubmed]
  28. Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension. Rossi, G.P., Ganzaroli, C., Cesari, M., Maresca, A., Plebani, M., Nussdorfer, G.G., Pessina, A.C. Cardiovasc. Res. (2003) [Pubmed]
  29. Altered regulation of endothelin A receptor subtype in the cerebral arterioles in response to a Japanese-style diet, in stroke-prone hypertensive rats. Rossi, G.P., Colonna, S., Belloni, A.S., Savoia, C., Albertin, G., Nussdorfer, G.G., Hagiwara, H., Rubattu, S., Volpe, M. J. Hypertens. (2003) [Pubmed]
  30. Dual ACE and NEP inhibitors: a review of the pharmacological properties of MDL 100240. Rossi, G.P. Cardiovasc. Drug. Rev (2003) [Pubmed]
  31. The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. Rossi, G.P., Cesari, M., Zanchetta, M., Colonna, S., Maiolino, G., Pedon, L., Cavallin, M., Maiolino, P., Pessina, A.C. J. Am. Coll. Cardiol. (2003) [Pubmed]
  32. The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. Rossi, G.P., Taddei, S., Virdis, A., Cavallin, M., Ghiadoni, L., Favilla, S., Versari, D., Sudano, I., Pessina, A.C., Salvetti, A. J. Am. Coll. Cardiol. (2003) [Pubmed]
  33. Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients. Rossi, G.P., Cesari, M., De Toni, R., Zanchetta, M., Maiolino, G., Pedon, L., Ganzaroli, C., Maiolino, P., Pessina, A.C. Circulation (2003) [Pubmed]
  34. Comparative effects of the dual ACE-NEP inhibitor MDL-100,240 and ramipril on hypertension and cardiovascular disease in endogenous angiotensin II-dependent hypertension. Rossi, G.P., Bova, S., Sacchetto, A., Rizzoni, D., Agabiti-Rosei, E., Neri, G., Nussdorfer, G.G., Pessina, A.C. Am. J. Hypertens. (2002) [Pubmed]
  35. Renal vein renin measurements accurately identify renovascular hypertension caused by total occlusion of the renal artery. Rossi, G.P., Cesari, M., Chiesura-Corona, M., Miotto, D., Semplicini, A., Pessina, A.C. J. Hypertens. (2002) [Pubmed]
  36. Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension. Rossi, G.P., Cavallin, M., Belloni, A.S., Mazzocchi, G., Nussdorfer, G.G., Pessina, A.C., Sartore, S. Cardiovasc. Res. (2002) [Pubmed]
  37. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Rossi, G.P., Di Bello, V., Ganzaroli, C., Sacchetto, A., Cesari, M., Bertini, A., Giorgi, D., Scognamiglio, R., Mariani, M., Pessina, A.C. Hypertension (2002) [Pubmed]
  38. Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor. Rossi, G.P., Cavallin, M., Rizzoni, D., Bova, S., Mazzocchi, G., Agabiti-Rosei, E., Nussdorfer, G.G., Pessina, A.C. J. Hypertens. (2002) [Pubmed]
  39. The endothelin-aldosterone axis and cardiovascular diseases. Rossi, G.P., Cavallin, M., Nussdorfer, G.G., Pessina, A.C. J. Cardiovasc. Pharmacol. (2001) [Pubmed]
 
WikiGenes - Universities